Incorporation of simian virus 5 fusion protein into murine leukemia virus particles and its effect on the co-incorporation of retroviral envelope glycoproteins

Virology

Volumn 267, Issue 1, 2000, Pages 49-57

  Hatziioannou, Theodora ^a   Russell, Stephen J ^b   Cosset, François Loïc ^a  

^a UNIVERSITÉ DE LYON   (France)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POL PROTEIN; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; EXPRESSION VECTOR; MOLONEY LEUKEMIA ONCOVIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS; VIRUS EXPRESSION;

MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; ONCOVIRINAE; PARAMYXOVIRIDAE; PRIMATES; RNA VIRUSES; RODENTIA; SIMIAE; SIMIAN PARAINFLUENZA VIRUS 5; SIMIAN VIRUS;

EID: 0034141367     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0091     Document Type: Article

References (27)

1. Bagai S., Lamb R. A. Quantitative measurement of paramyxovirus fusion: Differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:1995;6712-6719.
2. Cosset F.-L., Morling F. J., Takeuchi Y., Weiss R. A., Collins M. K. L., Russell S. J. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:1995a;6314-6322.
3. Cosset F.-L., Russell S. J. Targeting retrovirus entry. Gene Ther. 3:1996;946-956.
4. Cosset F.-L., Takeuchi Y., Battini J. L., Weiss R. A., Collins M. K. L. High titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:1995b;7430-7436.
5. Cosson P. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15:1996;5783-5788.
6. Denesvre C., Carrington C., Corbin A., Takeuchi Y., Cosset F.-L., Schulz T., Sitbon M., Sonigo P. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions. J. Virol. 70:1996;4380-4386.
7. Deng R., Wang Z., Mirza A. M., Iorio R. M. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology. 209:1995;457-469.
8. Emi N., Friedmann T., Yee J. K. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65:1991;1202-1207.
9. Hatziioannou T., Valsesia-Wittmann S., Russell S., Cosset F.-L. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J. Virol. 72:1998;5313-5317.
10. Horvath C. M., Paterson R. G., Shaughnessy M. A., Wood R., Lamb R. A. Biological activity of paramyxovirus fusion proteins: Factors influencing formation of syncytia. J. Virol. 66:1992;4564-4569.
11. Kozak S. L., Siess D. C., Kavanaugh M. P., Miller A. D., Kabat D. The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species. J. Virol. 69:1995;3433-3440.
12. Lamb R. A. Paramyxovirus fusion: A hypothesis for changes. Virology. 197:1993;1-11.
13. Landau N. R., Littman D. R. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66:1992;5110-5113.
14. Lindemann D., Bock M., Schweizer M., Rethwilm A. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:1997;4815-4820.
15. Lodge R., Delamarre L., Lalonde J. P., Alvarado J., Sanders D. A., Dokhelar M. C., Cohen E. A., Lemay G. Two distinct oncornaviruses harbor an intracytoplasmic tyrosine-based basolateral targeting signal in their viral envelope glycoprotein. J. Virol. 71:1997;5696-5702.
16. + cells. J. Virol. 71:1997;3341-3345.
17. McClure M. O., Sommerfelt M. A., Marsh M., Weiss R. A. The pH independence of mammalian retrovirus infection. J. Gen. Virol. 71:1990;767-773.
18. Rein A., Mirro J., Haynes J. G., Ernst S. M., Nagashima K. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus env protein. J. Virol. 68:1994;1773-1781.
19. Russell R., Paterson R. G., Lamb R. A. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology. 199:1994;160-168.
20. Schnierle B. S., Moritz D., Jeschke M., Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther. 3:1996;334-342.
21. Spiegel M., Bitzer M., Schenk A., Rossmann H., Neubert W. J., Seidler U., Gregor M., Lauer U. Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J. Virol. 72:1998;5269-5302.
22. Suomalainen M., Garoff H. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus. J. Virol. 68:1994;4879-4889.
23. Takeuchi Y., Cosset F. L., Lachmann P. J., Okada H., Weiss R. A., Collins M. K. L. Type C retrovirus inactivation by human complement is determined by both the viral genome and producer cell. J. Virol. 68:1994;8001-8007.
24. Weclewicz K., Ekstrom M., Kristensson K., Garoff H. Specific interactions between retrovirus Env and Gag proteins in rat neurons. J. Virol. 72:1998;2832-2845.
25. Wool-Lewis R. J., Bates P. Characterization of Ebola virus entry using pseudotyped viruses: Identification of receptor-deficient cell lines. J. Virol. 72:1998;3155-3160.
26. Yao Q., Hu X., Compans R. W. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J. Virol. 71:1997;650-656.
27. Yee J. K., Friedmann T., Burns J. C. Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol. 43:1994;99-112.